ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Warsaw
About this trial
The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to:
* Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.
Eligibility criteria
Qualifiers
tricuspid regurgitation
qualification for transcatheter tricuspid valve intervention
Disqualifiers
tricuspid regurgitation qualified for surgical treatment
concomitant left heart valve disease qualified for surgical treatment
multivessel coronary artery disease qualified for coronary artery bypass grafting
lack of patient's consent to enter the registry
Trial design
Treatments tested in this trial
- Transcatheter edge-to-edge repair
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Medical University of Warsaw
Lead sponsor
Poznan University of Medical Sciences
Collaborator
Medical University of Gdansk
Collaborator
National Institute of Cardiology, Warsaw, Poland
Collaborator
Medical University of Silesia
Collaborator
Jagiellonian University
Collaborator
Source ClinicalTrials.gov